查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1812387

类器官市场

Organoids Market
出版日期: | 出版商: Transparency Market Research | 英文 206 Pages | 商品交期: 2-10个工作天内

价格

类器官市场-报告范围

TMR 的全球类器官市场报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2025 年至 2035 年期间全球类器官市场的收入，以 2025 年为基准年，2035 年为预测年。报告中也提供了 2025 年至 2035 年全球类器官市场的年复合成长率(CAGR %)。

本报告经过广泛的研究后编写。主要研究工作量较大，分析师访问了关键意见领袖、产业领袖和舆论领袖。次要研究则参考了主要厂商的产品资料、年度报告、新闻稿和相关文件，以了解两轮车导航显示器市场。

市场概况
2024年的市场价值 11亿美元
2035年的市场价值 42亿美元
复合年增长率 13.4%

本报告深入探讨了全球两轮车导航显示器市场的竞争格局。该报告已确定全球类器官市场的主要参与者，并根据其各项属性对每位参与者进行了分析。本报告涵盖了全球类器官市场参与者的属性，包括公司概况、财务状况、近期发展和 SWOT 分析。

全球类器官市场报告解答的关键问题：

  • 预测期内，所有地区的血液分离术销售额/收入为何？
  • 全球两轮车导航显示器市场有哪些机会？
  • 市场的主要驱动因素、限制因素、机会和威胁是什么？
  • 在预测期内，哪个区域市场将以最快的复合年增长率扩张？
  • 预计哪个领域将在 2035 年创造全球最高收入？
  • 预测期内，哪个细分市场预计以最高复合年增长率扩张？
  • 在全球市场中经营的不同公司的市场地位如何？

类器官市场—研究目标与研究方法

这份关于全球类器官市场的综合报告首先概述了研究范围和目标。报告详细阐述了本研究的目标、市场中的主要供应商和分销商，以及产品审批的监管情况。

为了方便阅读，本报告采用章节式编排，每个章节又细分为多个小节。报告包含详尽的图表，并适当穿插。各关键细分市场的实际值和预测值以图形方式呈现，视觉上引人入胜。此外，报告也便于读者比较过去和预测期末各关键细分市场的市占率。

本报告从产品、最终用户和地区角度分析了全球类器官市场。该报告对每个标准下的关键细分市场进行了深入研究，并提供了2035年底每个细分市场的市场份额。这些宝贵的见解使市场利益相关者能够在全球两轮车导航显示器市场投资时做出明智的商业决策。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概况

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球类器官市场分析与预测

第五章：关键见解

  • 主要地区/国家的医疗保健支出
  • 类器官技术的最新进展
  • 类器官的定价趋势
  • 主要地区/国家的监管情况
  • 波特五力分析
  • PESTEL分析
  • 价值链分析
  • 最终用户的关键购买指标
  • 新市场进入者的市场进入策略
  • 重要产业事件（合作伙伴关係、协作、产品审批、併购）
  • 主要竞争对手提供的关键产品的基准化分析

第六章：全球市场分析与预测：按类器官类型

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年各类类器官市场价值预测
    • 胃类器官
    • 肠道类器官
    • 肝臟类器官
    • 肺类器官
    • 脑类器官
    • 肾臟类器官
    • 大肠直肠类器官
    • 乳腺类器官
    • 前列腺类器官
    • 皮肤类器官
    • 视网膜类器官
    • 其他的
  • 不同类型类器官的市场吸引力

第七章：全球市场分析与预测：依来源

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年各来源市场价值预测
    • 多能干细胞（PSC）
      • 胚胎干细胞（ESC）
      • 诱导性多能干细胞（iPSC）
    • 成体干细胞（ASC）
    • 患者来源的类器官
  • 市场吸引力（按来源）

第八章：全球市场分析与预测：按应用

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年各应用市场价值预测
    • 发育生物学
    • 再生医学
    • 疾病建模
    • 药物毒性和疗效测试
    • 生物标记发现
    • 其他的
  • 按应用分類的市场吸引力

第九章：全球市场分析与预测：按可用性

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年可用性市值预测
    • 即用型类器官
    • 可自订的类器官
  • 可用性的市场吸引力

第十章：全球市场分析与预测：依储存条件

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年按储存条件分類的市场价值预测
    • 耐储存的类器官
    • 冷冻保存的类器官
  • 不同储存条件的市场吸引力

第 11 章：全球市场分析与预测：按最终用户

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年终端用户市场价值预测
    • 製药和生物技术公司
    • 合约研究组织（CRO）
    • 学术和研究机构
  • 最终用户的市场吸引力

第十二章：全球市场分析及预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十三章：北美市场分析与预测

  • 我们
  • 加拿大

第14章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 瑞士
  • 荷兰
  • 欧洲其他地区

第十五章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲和纽西兰
  • 亚太其他地区

第十六章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区

第 17 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 18 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024年）
  • 公司简介
    • Danaher Corporation
    • Merck KGaA
    • 3Dnamics Inc.
    • ATCC
    • STEMCELL Technologies
    • CelVivo ApS
    • Emulate, Inc.
    • Newcells Biotech
    • ACROBiosystems
    • Corning Incorporated
    • Pandorum Technologies Pvt. Ltd.
    • MIMETAS BV
    • Organovo Holdings Inc.
    • Crown Bioscience
    • OrganoTherapeutics SARL
Product Code: TMRGL73363

Organoids Market- Scope of Report

TMR's report on the global Organoids Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Organoids Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Organoids Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Organoids Market .

Market Snapshot
Market Value in 2024US$ 1.1 Bn
Market Value in 2035US$ 4.2 Bn
CAGR13.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Organoids Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Organoids Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Organoids Market .

The report delves into the competitive landscape of the global Organoids Market . Key players operating in the global Organoids Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Organoids Marketprofiled in this report.

Key Questions Answered in Global Organoids MarketReport:

  • What are the opportunities in the global Organoids Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Organoids Market- Research Objectives and Research Approach

The comprehensive report on the global Organoids Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Organoids Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Organoids Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Organoids Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Organoids Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Recent Advancements in Organoid Technology
  • 5.3. Pricing Trends for Organoids
  • 5.4. Regulatory Scenario across Key Regions / Countries
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. PESTEL Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Key Purchase Metrics for End-users
  • 5.9. Go-to-Market Strategy for New Market Entrants
  • 5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
  • 5.11. Benchmarking of Key Products Offered by the Leading Competitors

6. Global Organoids Market Analysis and Forecasts, By Type of Organoid

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 6.3.1. Stomach Organoids
    • 6.3.2. Intestinal Organoids
    • 6.3.3. Liver Organoids
    • 6.3.4. Lung Organoids
    • 6.3.5. Brain Organoids
    • 6.3.6. Kidney Organoids
    • 6.3.7. Colorectal Organoids
    • 6.3.8. Breast Organoids
    • 6.3.9. Prostate Organoids
    • 6.3.10. Skin Organoids
    • 6.3.11. Retina Organoids
    • 6.3.12. Others
  • 6.4. Market Attractiveness By Type of Organoid

7. Global Organoids Market Analysis and Forecasts, By Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Source, 2020 to 2035
    • 7.3.1. Pluripotent Stem Cells (PSCs)
      • 7.3.1.1. Embryonic Stem Cells (ESCs)
      • 7.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 7.3.2. Adult Stem Cells (ASCs)
    • 7.3.3. Patient-derived Organoids
  • 7.4. Market Attractiveness By Source

8. Global Organoids Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2020 to 2035
    • 8.3.1. Developmental Biology
    • 8.3.2. Regenerative Medicine
    • 8.3.3. Disease Modelling
    • 8.3.4. Drug Toxicity and Efficacy Testing
    • 8.3.5. Biomarker Discovery
    • 8.3.6. Others
  • 8.4. Market Attractiveness By Application

9. Global Organoids Market Analysis and Forecasts, By Usability

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Usability, 2020 to 2035
    • 9.3.1. Ready-to-Use Organoids
    • 9.3.2. Customizable Organoids
  • 9.4. Market Attractiveness By Usability

10. Global Organoids Market Analysis and Forecasts, By Storage Conditions

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 10.3.1. Shelf-stable Organoids
    • 10.3.2. Cryopreserved Organoids
  • 10.4. Market Attractiveness By Storage Conditions

11. Global Organoids Market Analysis and Forecasts, By End-user

  • 11.1. Introduction & Definition
  • 11.2. Key Findings / Developments
  • 11.3. Market Value Forecast By End-user, 2020 to 2035
    • 11.3.1. Pharmaceutical and Biotechnology Companies
    • 11.3.2. Contract Research Organizations (CROs)
    • 11.3.3. Academic and Research Institutions
  • 11.4. Market Attractiveness By End-user

12. Global Organoids Market Analysis and Forecasts, By Region

  • 12.1. Key Findings
  • 12.2. Market Value Forecast By Region
    • 12.2.1. North America
    • 12.2.2. Europe
    • 12.2.3. Asia Pacific
    • 12.2.4. Latin America
    • 12.2.5. Middle East & Africa
  • 12.3. Market Attractiveness By Region

13. North America Organoids Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 13.2.1. Stomach Organoids
    • 13.2.2. Intestinal Organoids
    • 13.2.3. Liver Organoids
    • 13.2.4. Lung Organoids
    • 13.2.5. Brain Organoids
    • 13.2.6. Kidney Organoids
    • 13.2.7. Colorectal Organoids
    • 13.2.8. Breast Organoids
    • 13.2.9. Prostate Organoids
    • 13.2.10. Skin Organoids
    • 13.2.11. Retina Organoids
    • 13.2.12. Others
  • 13.3. Market Value Forecast By Source, 2020 to 2035
    • 13.3.1. Pluripotent Stem Cells (PSCs)
      • 13.3.1.1. Embryonic Stem Cells (ESCs)
      • 13.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 13.3.2. Adult Stem Cells (ASCs)
    • 13.3.3. Patient-derived Organoids
  • 13.4. Market Value Forecast By Application, 2020 to 2035
    • 13.4.1. Developmental Biology
    • 13.4.2. Regenerative Medicine
    • 13.4.3. Disease Modelling
    • 13.4.4. Drug Toxicity and Efficacy Testing
    • 13.4.5. Biomarker Discovery
    • 13.4.6. Others
  • 13.5. Market Value Forecast By Usability, 2020 to 2035
    • 13.5.1. Ready-to-Use Organoids
    • 13.5.2. Customizable Organoids
  • 13.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 13.6.1. Shelf-stable Organoids
    • 13.6.2. Cryopreserved Organoids
  • 13.7. Market Value Forecast By End-user, 2020 to 2035
    • 13.7.1. Pharmaceutical and Biotechnology Companies
    • 13.7.2. Contract Research Organizations (CROs)
    • 13.7.3. Academic and Research Institutions
  • 13.8. Market Value Forecast By Country , 2020 to 2035
    • 13.8.1. U.S.
    • 13.8.2. Canada
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Type of Organoid
    • 13.9.2. By Source
    • 13.9.3. By Application
    • 13.9.4. By Usability
    • 13.9.5. By Storage Conditions
    • 13.9.6. By End-user
    • 13.9.7. By Country

14. Europe Organoids Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 14.2.1. Stomach Organoids
    • 14.2.2. Intestinal Organoids
    • 14.2.3. Liver Organoids
    • 14.2.4. Lung Organoids
    • 14.2.5. Brain Organoids
    • 14.2.6. Kidney Organoids
    • 14.2.7. Colorectal Organoids
    • 14.2.8. Breast Organoids
    • 14.2.9. Prostate Organoids
    • 14.2.10. Skin Organoids
    • 14.2.11. Retina Organoids
    • 14.2.12. Others
  • 14.3. Market Value Forecast By Source, 2020 to 2035
    • 14.3.1. Pluripotent Stem Cells (PSCs)
      • 14.3.1.1. Embryonic Stem Cells (ESCs)
      • 14.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 14.3.2. Adult Stem Cells (ASCs)
    • 14.3.3. Patient-derived Organoids
  • 14.4. Market Value Forecast By Application, 2020 to 2035
    • 14.4.1. Developmental Biology
    • 14.4.2. Regenerative Medicine
    • 14.4.3. Disease Modelling
    • 14.4.4. Drug Toxicity and Efficacy Testing
    • 14.4.5. Biomarker Discovery
    • 14.4.6. Others
  • 14.5. Market Value Forecast By Usability, 2020 to 2035
    • 14.5.1. Ready-to-Use Organoids
    • 14.5.2. Customizable Organoids
  • 14.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 14.6.1. Shelf-stable Organoids
    • 14.6.2. Cryopreserved Organoids
  • 14.7. Market Value Forecast By End-user, 2020 to 2035
    • 14.7.1. Pharmaceutical and Biotechnology Companies
    • 14.7.2. Contract Research Organizations (CROs)
    • 14.7.3. Academic and Research Institutions
  • 14.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 14.8.1. Germany
    • 14.8.2. UK
    • 14.8.3. France
    • 14.8.4. Italy
    • 14.8.5. Spain
    • 14.8.6. Switzerland
    • 14.8.7. The Netherlands
    • 14.8.8. Rest of Europe
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Type of Organoid
    • 14.9.2. By Source
    • 14.9.3. By Application
    • 14.9.4. By Usability
    • 14.9.5. By Storage Conditions
    • 14.9.6. By End-user
    • 14.9.7. By Country / Sub-region

15. Asia Pacific Organoids Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 15.2.1. Stomach Organoids
    • 15.2.2. Intestinal Organoids
    • 15.2.3. Liver Organoids
    • 15.2.4. Lung Organoids
    • 15.2.5. Brain Organoids
    • 15.2.6. Kidney Organoids
    • 15.2.7. Colorectal Organoids
    • 15.2.8. Breast Organoids
    • 15.2.9. Prostate Organoids
    • 15.2.10. Skin Organoids
    • 15.2.11. Retina Organoids
    • 15.2.12. Others
  • 15.3. Market Value Forecast By Source, 2020 to 2035
    • 15.3.1. Pluripotent Stem Cells (PSCs)
      • 15.3.1.1. Embryonic Stem Cells (ESCs)
      • 15.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 15.3.2. Adult Stem Cells (ASCs)
    • 15.3.3. Patient-derived Organoids
  • 15.4. Market Value Forecast By Application, 2020 to 2035
    • 15.4.1. Developmental Biology
    • 15.4.2. Regenerative Medicine
    • 15.4.3. Disease Modelling
    • 15.4.4. Drug Toxicity and Efficacy Testing
    • 15.4.5. Biomarker Discovery
    • 15.4.6. Others
  • 15.5. Market Value Forecast By Usability, 2020 to 2035
    • 15.5.1. Ready-to-Use Organoids
    • 15.5.2. Customizable Organoids
  • 15.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 15.6.1. Shelf-stable Organoids
    • 15.6.2. Cryopreserved Organoids
  • 15.7. Market Value Forecast By End-user, 2020 to 2035
    • 15.7.1. Pharmaceutical and Biotechnology Companies
    • 15.7.2. Contract Research Organizations (CROs)
    • 15.7.3. Academic and Research Institutions
  • 15.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 15.8.1. China
    • 15.8.2. India
    • 15.8.3. Japan
    • 15.8.4. South Korea
    • 15.8.5. Australia & New Zealand
    • 15.8.6. Rest of Asia Pacific
  • 15.9. Market Attractiveness Analysis
    • 15.9.1. By Type of Organoid
    • 15.9.2. By Source
    • 15.9.3. By Application
    • 15.9.4. By Usability
    • 15.9.5. By Storage Conditions
    • 15.9.6. By End-user
    • 15.9.7. By Country / Sub-region

16. Latin America Organoids Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 16.2.1. Stomach Organoids
    • 16.2.2. Intestinal Organoids
    • 16.2.3. Liver Organoids
    • 16.2.4. Lung Organoids
    • 16.2.5. Brain Organoids
    • 16.2.6. Kidney Organoids
    • 16.2.7. Colorectal Organoids
    • 16.2.8. Breast Organoids
    • 16.2.9. Prostate Organoids
    • 16.2.10. Skin Organoids
    • 16.2.11. Retina Organoids
    • 16.2.12. Others
  • 16.3. Market Value Forecast By Source, 2020 to 2035
    • 16.3.1. Pluripotent Stem Cells (PSCs)
      • 16.3.1.1. Embryonic Stem Cells (ESCs)
      • 16.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 16.3.2. Adult Stem Cells (ASCs)
    • 16.3.3. Patient-derived Organoids
  • 16.4. Market Value Forecast By Application, 2020 to 2035
    • 16.4.1. Developmental Biology
    • 16.4.2. Regenerative Medicine
    • 16.4.3. Disease Modelling
    • 16.4.4. Drug Toxicity and Efficacy Testing
    • 16.4.5. Biomarker Discovery
    • 16.4.6. Others
  • 16.5. Market Value Forecast By Usability, 2020 to 2035
    • 16.5.1. Ready-to-Use Organoids
    • 16.5.2. Customizable Organoids
  • 16.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 16.6.1. Shelf-stable Organoids
    • 16.6.2. Cryopreserved Organoids
  • 16.7. Market Value Forecast By End-user, 2020 to 2035
    • 16.7.1. Pharmaceutical and Biotechnology Companies
    • 16.7.2. Contract Research Organizations (CROs)
    • 16.7.3. Academic and Research Institutions
  • 16.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 16.8.1. Brazil
    • 16.8.2. Mexico
    • 16.8.3. Argentina
    • 16.8.4. Rest of Latin America
  • 16.9. Market Attractiveness Analysis
    • 16.9.1. By Type of Organoid
    • 16.9.2. By Source
    • 16.9.3. By Application
    • 16.9.4. By Usability
    • 16.9.5. By Storage Conditions
    • 16.9.6. By End-user
    • 16.9.7. By Country / Sub-region

17. Middle East & Africa Organoids Market Analysis and Forecast

  • 17.1. Introduction
    • 17.1.1. Key Findings
  • 17.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 17.2.1. Stomach Organoids
    • 17.2.2. Intestinal Organoids
    • 17.2.3. Liver Organoids
    • 17.2.4. Lung Organoids
    • 17.2.5. Brain Organoids
    • 17.2.6. Kidney Organoids
    • 17.2.7. Colorectal Organoids
    • 17.2.8. Breast Organoids
    • 17.2.9. Prostate Organoids
    • 17.2.10. Skin Organoids
    • 17.2.11. Retina Organoids
    • 17.2.12. Others
  • 17.3. Market Value Forecast By Source, 2020 to 2035
    • 17.3.1. Pluripotent Stem Cells (PSCs)
      • 17.3.1.1. Embryonic Stem Cells (ESCs)
      • 17.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 17.3.2. Adult Stem Cells (ASCs)
    • 17.3.3. Patient-derived Organoids
  • 17.4. Market Value Forecast By Application, 2020 to 2035
    • 17.4.1. Developmental Biology
    • 17.4.2. Regenerative Medicine
    • 17.4.3. Disease Modelling
    • 17.4.4. Drug Toxicity and Efficacy Testing
    • 17.4.5. Biomarker Discovery
    • 17.4.6. Others
  • 17.5. Market Value Forecast By Usability, 2020 to 2035
    • 17.5.1. Ready-to-Use Organoids
    • 17.5.2. Customizable Organoids
  • 17.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 17.6.1. Shelf-stable Organoids
    • 17.6.2. Cryopreserved Organoids
  • 17.7. Market Value Forecast By End-user, 2020 to 2035
    • 17.7.1. Pharmaceutical and Biotechnology Companies
    • 17.7.2. Contract Research Organizations (CROs)
    • 17.7.3. Academic and Research Institutions
  • 17.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 17.8.1. GCC Countries
    • 17.8.2. South Africa
    • 17.8.3. Rest of Middle East & Africa
  • 17.9. Market Attractiveness Analysis
    • 17.9.1. By Type of Organoid
    • 17.9.2. By Source
    • 17.9.3. By Application
    • 17.9.4. By Usability
    • 17.9.5. By Storage Conditions
    • 17.9.6. By End-user
    • 17.9.7. By Country / Sub-region

18. Competition Landscape

  • 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 18.2. Market Share Analysis By Company (2024)
  • 18.3. Company Profiles
    • 18.3.1. Danaher Corporation
      • 18.3.1.1. Company Overview
      • 18.3.1.2. Financial Overview
      • 18.3.1.3. Product Portfolio
      • 18.3.1.4. Business Strategies
      • 18.3.1.5. Recent Developments
    • 18.3.2. Merck KGaA
      • 18.3.2.1. Company Overview
      • 18.3.2.2. Financial Overview
      • 18.3.2.3. Product Portfolio
      • 18.3.2.4. Business Strategies
      • 18.3.2.5. Recent Developments
    • 18.3.3. 3Dnamics Inc.
      • 18.3.3.1. Company Overview
      • 18.3.3.2. Financial Overview
      • 18.3.3.3. Product Portfolio
      • 18.3.3.4. Business Strategies
      • 18.3.3.5. Recent Developments
    • 18.3.4. ATCC
      • 18.3.4.1. Company Overview
      • 18.3.4.2. Financial Overview
      • 18.3.4.3. Product Portfolio
      • 18.3.4.4. Business Strategies
      • 18.3.4.5. Recent Developments
    • 18.3.5. STEMCELL Technologies
      • 18.3.5.1. Company Overview
      • 18.3.5.2. Financial Overview
      • 18.3.5.3. Product Portfolio
      • 18.3.5.4. Business Strategies
      • 18.3.5.5. Recent Developments
    • 18.3.6. CelVivo ApS
      • 18.3.6.1. Company Overview
      • 18.3.6.2. Financial Overview
      • 18.3.6.3. Product Portfolio
      • 18.3.6.4. Business Strategies
      • 18.3.6.5. Recent Developments
    • 18.3.7. Emulate, Inc.
      • 18.3.7.1. Company Overview
      • 18.3.7.2. Financial Overview
      • 18.3.7.3. Product Portfolio
      • 18.3.7.4. Business Strategies
      • 18.3.7.5. Recent Developments
    • 18.3.8. Newcells Biotech
      • 18.3.8.1. Company Overview
      • 18.3.8.2. Financial Overview
      • 18.3.8.3. Product Portfolio
      • 18.3.8.4. Business Strategies
      • 18.3.8.5. Recent Developments
    • 18.3.9. ACROBiosystems
      • 18.3.9.1. Company Overview
      • 18.3.9.2. Financial Overview
      • 18.3.9.3. Product Portfolio
      • 18.3.9.4. Business Strategies
      • 18.3.9.5. Recent Developments
    • 18.3.10. Corning Incorporated
      • 18.3.10.1. Company Overview
      • 18.3.10.2. Financial Overview
      • 18.3.10.3. Product Portfolio
      • 18.3.10.4. Business Strategies
      • 18.3.10.5. Recent Developments
    • 18.3.11. Pandorum Technologies Pvt. Ltd.
      • 18.3.11.1. Company Overview
      • 18.3.11.2. Financial Overview
      • 18.3.11.3. Product Portfolio
      • 18.3.11.4. Business Strategies
      • 18.3.11.5. Recent Developments
    • 18.3.12. MIMETAS B.V.
      • 18.3.12.1. Company Overview
      • 18.3.12.2. Financial Overview
      • 18.3.12.3. Product Portfolio
      • 18.3.12.4. Business Strategies
      • 18.3.12.5. Recent Developments
    • 18.3.13. Organovo Holdings Inc.
      • 18.3.13.1. Company Overview
      • 18.3.13.2. Financial Overview
      • 18.3.13.3. Product Portfolio
      • 18.3.13.4. Business Strategies
      • 18.3.13.5. Recent Developments
    • 18.3.14. Crown Bioscience
      • 18.3.14.1. Company Overview
      • 18.3.14.2. Financial Overview
      • 18.3.14.3. Product Portfolio
      • 18.3.14.4. Business Strategies
      • 18.3.14.5. Recent Developments
    • 18.3.15. OrganoTherapeutics SARL
      • 18.3.15.1. Company Overview
      • 18.3.15.2. Financial Overview
      • 18.3.15.3. Product Portfolio
      • 18.3.15.4. Business Strategies
      • 18.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 02: Global Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 03: Global Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 04: Global Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 06: Global Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 07: Global Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 08: Global Organoids Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 09: North America Organoids Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 10: North America Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 11: North America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 12: North America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 13: North America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 14: North America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 15: North America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 16: North America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 17: Europe Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 18: Europe Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 19: Europe Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 20: Europe Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 21: Europe Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 22: Europe Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 23: Europe Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 24: Europe Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Asia Pacific Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 27: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 28: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 29: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 31: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 32: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 33: Latin America Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 34: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 35: Latin America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 36: Latin America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 37: Latin America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 38: Latin America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 39: Latin America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 40: Latin America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 41: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 42: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 43: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 44: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 45: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 46: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 47: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 48: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 02: Global Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 03: Global Organoids Market Revenue (US$ Bn), by Stomach Organoids, 2020 to 2035
  • Figure 04: Global Organoids Market Revenue (US$ Bn), by Intestinal Organoids, 2020 to 2035
  • Figure 05: Global Organoids Market Revenue (US$ Bn), by Liver Organoids, 2020 to 2035
  • Figure 06: Global Organoids Market Revenue (US$ Bn), by Lung Organoids, 2020 to 2035
  • Figure 07: Global Organoids Market Revenue (US$ Bn), by Brain Organoids, 2020 to 2035
  • Figure 08: Global Organoids Market Revenue (US$ Bn), by Kidney Organoids, 2020 to 2035
  • Figure 09: Global Organoids Market Revenue (US$ Bn), by Colorectal Organoids, 2020 to 2035
  • Figure 10: Global Organoids Market Revenue (US$ Bn), by Breast Organoids, 2020 to 2035
  • Figure 11: Global Organoids Market Revenue (US$ Bn), by Prostate Organoids, 2020 to 2035
  • Figure 12: Global Organoids Market Revenue (US$ Bn), by Skin Organoids, 2020 to 2035
  • Figure 13: Global Organoids Market Revenue (US$ Bn), by Retina Organoids, 2020 to 2035
  • Figure 14: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 15: Global Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 16: Global Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 17: Global Organoids Market Revenue (US$ Bn), by Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Figure 18: Global Organoids Market Revenue (US$ Bn), by Adult Stem Cells (ASCs), 2020 to 2035
  • Figure 19: Global Organoids Market Revenue (US$ Bn), by Patient-derived Organoids, 2020 to 2035
  • Figure 20: Global Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 21: Global Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 22: Global Organoids Market Revenue (US$ Bn), by Developmental Biology, 2020 to 2035
  • Figure 23: Global Organoids Market Revenue (US$ Bn), by Regenerative Medicine, 2020 to 2035
  • Figure 24: Global Organoids Market Revenue (US$ Bn), by Disease Modelling, 2020 to 2035
  • Figure 25: Global Organoids Market Revenue (US$ Bn), by Drug Toxicity and Efficacy Testing, 2020 to 2035
  • Figure 26: Global Organoids Market Revenue (US$ Bn), by Biomarker Discovery, 2020 to 2035
  • Figure 27: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 28: Global Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 29: Global Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 30: Global Organoids Market Revenue (US$ Bn), by Ready-to-Use Organoids, 2020 to 2035
  • Figure 31: Global Organoids Market Revenue (US$ Bn), by Customizable Organoids, 2020 to 2035
  • Figure 32: Global Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 33: Global Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 34: Global Organoids Market Revenue (US$ Bn), by Shelf-stable Organoids, 2020 to 2035
  • Figure 35: Global Organoids Market Revenue (US$ Bn), by Cryopreserved Organoids, 2020 to 2035
  • Figure 36: Global Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 37: Global Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 38: Global Organoids Market Revenue (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020 to 2035
  • Figure 39: Global Organoids Market Revenue (US$ Bn), by Contract Research Organizations (CROs), 2020 to 2035
  • Figure 40: Global Organoids Market Revenue (US$ Bn), by Academic and Research Institutions, 2020 to 2035
  • Figure 41: Global Organoids Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 42: Global Organoids Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 43: North America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 44: North America Organoids Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 45: North America Organoids Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 46: North America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 47: North America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 48: North America Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 49: North America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 50: North America Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 51: North America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 52: North America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 53: North America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 54: North America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 55: North America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 56: North America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: North America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 58: Europe Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 59: Europe Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Europe Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 61: Europe Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 62: Europe Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 63: Europe Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 64: Europe Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 65: Europe Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 66: Europe Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 67: Europe Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 68: Europe Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 69: Europe Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 70: Europe Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 71: Europe Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 72: Europe Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 73: Asia Pacific Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 74: Asia Pacific Organoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Asia Pacific Organoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 76: Asia Pacific Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 77: Asia Pacific Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 78: Asia Pacific Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 79: Asia Pacific Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 80: Asia Pacific Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 81: Asia Pacific Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 82: Asia Pacific Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 83: Asia Pacific Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 84: Asia Pacific Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 85: Asia Pacific Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 86: Asia Pacific Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 87: Asia Pacific Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 88: Latin America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 89: Latin America Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 90: Latin America Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 91: Latin America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 92: Latin America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 93: Latin America Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 94: Latin America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 95: Latin America Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 96: Latin America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 97: Latin America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 98: Latin America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 99: Latin America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 100: Latin America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 101: Latin America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 102: Latin America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 103: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 104: Middle East & Africa Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 105: Middle East & Africa Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 106: Middle East & Africa Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 107: Middle East & Africa Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 108: Middle East & Africa Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 109: Middle East & Africa Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 110: Middle East & Africa Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 111: Middle East & Africa Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 112: Middle East & Africa Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 113: Middle East & Africa Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 114: Middle East & Africa Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 115: Middle East & Africa Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 116: Middle East & Africa Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 117: Middle East & Africa Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035